Skip to main content
. 2020 Apr 25;20:558. doi: 10.1186/s12889-020-08642-4

Table 2.

Results of Decision Model and Sensitivity Analyses

Cost
($)
ΔC
($)
Outcome (QALYs) ΔE (QALYs) C/E
($/QALY)
ICER
($/QALY)
NMB
($)
Decision model
WTP = $50,000
 Non-almond 1524 Ref 0.94 Ref 1625 Dominated 45,373
 Almond 1161 −363 0.96 0.02 1211 46,794
WTP = $100,000
 Non-almond 1524 Ref 0.94 Ref 1625 Dominated 92,270
 Almond 1161 −363 0.96 0.02 1211 94,749
WTP = $200,000
 Non-almond 1524 Ref 0.94 Ref 1625 Dominated 186,064
 Almond 1161 −363 0.96 0.02 1211 190,658
Sensitivity–Probabilistic Sensitivity Analysis
 Non-almond 1555 ± 59 Ref 0.94 ± 0.0005 Ref 1658 ± 63 45,333 ± 84
 Almond 1589 ± 417 34 ± 414 0.94 ± 0.02 0.005 ± 0.02 1694 ± 474 −26,798 ± 814,514 45,542 ± 1245
Sensitivity–10-year model
 Non-almond 20,871 Ref 8.13 Ref 2566 Dominated 385,788
 Almond 15,120 −5750 8.37 0.24 1806 403,377
Sensitivity–cost of procedure
 Non-almond 1524 Ref 0.94 Ref 1625 Dominated 45,373
 Almond 1161 −363 0.96 0.02 1210 46,794
Sensitivity–cost of almond
 Non-almond 1524 Ref 0.94 Ref 1625 Dominated 45,373
 Higher cost of almond 1474 −50 0.96 0.02 1537 46,480
Sensitivity–CVD patients
 Non-almond 1213 Ref 0.86 Ref 1411 Dominated 41,766
 Almond 1022 −190 0.86 0.0001 1189 41,962

Abbreviations: C/E cost-effectiveness ratio, ICER incremental cost-effectiveness ratio, NMB net monetary benefit, QALY quality-adjusted life years, WTP willingness-to-pay